|
Company:
|
AXOGEN, INC. (AXGN)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
7/11/2013
|
|
CIK:
|
0000805928
|
|
Address:
|
13859 PROGRESS BLVD
SUITE 100
|
|
City, State, Zip:
|
ALACHUA, Florida 32615
|
|
Telephone:
|
(386) 462-6817
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$8.86
|
Change:
0.025 (0.28%)
|
Trade Time:
02:24 PM EST
|
Market Cap:
$266.82M
|
|
|
|
|
|
|
Description of Business
|
|
We are a leading medical technology company dedicated to peripheral nerve
repair. We provide products and education to improve surgical treatment
algorithms for peripheral nerve injuries. Our portfolio of regenerative medicine
products is available in the United States, Canada and several other countries
and includes Avance® Nerve Graft, an off-the-shelf processed human nerve
allograft for bridging severed nerves without the comorbidities associated with
a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa
extracellular matrix ("ECM") coaptation aid for tensionless repair of severed
nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to
wrap and protect injured peripheral nerves and reinforce the nerve
reconstruction while preventing soft tissue attachments.
|
|
|
|